Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cardiogenic shock rate soars in COVID-positive ACS

Key clinical point: In-hospital mortality was quadrupled in COVID-positive STEMI patients, compared with COVID-negative historical controls.

Major finding: COVID-positive STEMI patients had a 20.1% incidence of cardiogenic shock, compared with 8.7% in non-COVID historical controls.

Study details: This prospective registry included 266 COVID-positive patients who presented with ACS at 85 hospitals in the United Kingdom, Europe, and North America during March through August of 2020.

Disclosures: This international registry was funded free of commercial support.

Citation:

Gershlick A. TCT 2020.